Prime Medicine
PRME • NASDAQ
Prime Medicine is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Allan Reine, with a market cap of $633.7M.
Market Cap$633.7M
Employees234.0
CEOAllan Reine
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Prime Medicine FAQ
Common questions about Prime Medicine
Prime Medicine is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $1.2M.
Prime Medicine has approximately 234 employees.